Real-world experience of adverse reactions-necessitated rifampicin-sparing treatment for drug-susceptible pulmonary tuberculosis

Rifampicin is an important agent for tuberculosis treatment; however, it is often discontinued because of adverse reactions. The treatment regimen then can be administered as that for rifampicin-resistant tuberculosis, which can be toxic. We retrospectively reviewed 114 patients with drug-susceptibl...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyung-Jun, Lee, Ye Jin, Song, Myung Jin, Kwon, Byoung Soo, Kim, Yeon Wook, Lim, Sung Yoon, Lee, Yeon-Joo, Park, Jong Sun, Cho, Young-Jae, Lee, Choon-Taek, Lee, Jae Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338469/
https://www.ncbi.nlm.nih.gov/pubmed/37438379
http://dx.doi.org/10.1038/s41598-023-38394-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338469/
https://www.ncbi.nlm.nih.gov/pubmed/37438379
http://dx.doi.org/10.1038/s41598-023-38394-1

Ejemplares similares